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Purpose: To compare the surgical results of trabeculectomy and Ahmed glaucoma valve implantation after a 
previous failed trabeculectomy.
Methods: A retrospective comparative case series review was performed on 31 eye surgeries in 20 patients 
with primary congenital glaucoma who underwent trabeculectomy or Ahmed glaucoma valve implantation af-
ter a previous failed trabeculectomy with mitomycin C.
Results: The preoperative mean intraocular pressure was 25.5 mmHg in the trabeculectomy group and 26.9 
mmHg in the Ahmed glaucoma valve implantation group (p = 0.73). The 48-month postoperative mean intra-
ocular pressure was 19.6 mmHg in the trabeculectomy group and 20.2 mmHg in the Ahmed glaucoma valve 
implantation group (p = 0.95). The 12-month trabeculectomy success rate was 69%, compared with 64% for 
Ahmed glaucoma valve implantation, and the 48-month success rates were 42% and 36% for trabeculectomy 
and valve implantation, respectively. The success rates following the entire follow-up period were not signifi-
cantly different between the two groups (p > 0.05 by log rank test). Postoperative complications occurred in 
25% of the trabeculectomy-operated eyes and 9% of the Ahmed-implanted eyes (p = 0.38).
Conclusions: There was no significant difference in surgical outcome between the trabeculectomy and Ahmed 
glaucoma valve implantation groups, neither of which had favorable results. However, the trabeculectomy 
group demonstrated a higher prevalence of adverse complications such as post-operative endophthalmitis.
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The incidence of congenital glaucoma is low, but it is the 
most common form of pediatric glaucoma and an import-
ant cause of blindness [1]. The treatment of choice for con-
genital glaucoma is surgery, with angle surgery usually 
being performed first, followed by trabeculectomy or 
Ahmed glaucoma valve implantation, if the angle surgery 
fails [1,2]. However, even these interventions are not al-
ways effective for controlling intraocular pressure (IOP), 
and, when they fail, it can be difficult to decide on a next 
step. The aim of this study was to investigate and compare 
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the surgical results of trabeculectomy with those of Ahmed 
glaucoma valve implantation following a previous trabe-
culectomy failure in patients with primary congenital 
glaucoma.
Materials and Methods
With institutional review board approval, we completed 
a retrospective chart review of 167 congenital glaucoma 
patients who had undergone glaucoma surgery. Thirty-one 
eyes of 20 patients with primary congenital glaucoma who 
underwent trabeculectomy with mitomycin C (n = 20) or 
Ahmed glaucoma valve implantation (n = 11) after a previ-
ous failed trabeculectomy between June 1990 and April 
2007 were included in this study. This study followed the 
tenets of the Declaration of Helsinki. 
Diagnoses were confirmed with clinical features and 
signs, such as gonioscopic angle abnormality, enlargement 
of the corneal diameter, increase in axial length, optic 
nerve change, and persistently elevated IOP. Patients with 
other ocular or systemic abnormalities that could result in 
glaucoma, such as Axenfeld-Rieger syndrome, were ex-
cluded, as were patients with less than six months fol-
low-up time. All patients had a history of previous failed 
trabeculectomy. The following data were analyzed be-
tween the two groups: 1) preoperative and postoperative 
IOP, 2) number of glaucoma medications used during the 
preoperative and postoperative periods, 3) surgical compli-
cations, and 4) achievement of surgical success.
IOP was measured with a tonopen or, when possible, 
with a Goldmann applanation tonometer (GAT). Visual 
acuity was determined with a Teller acuity card or a Snel-
len acuity chart, when possible. A successful operation 
was defined as 1) intraocular ocular pressure between 5 
and 21 mmHg, 2) no decrease in vision due to complica-
tions or changes in IOP, and 3) no need for an additional 
glaucoma operation. Postoperative use of antiglaucoma 
medication was not a criterion of success or failure.
All surgeries were performed by a single surgeon (YJH). 
For trabeculectomy, a limbus-based conjunctival flap was 
prepared, followed by a rectangular half-thickness scleral 
flap measuring 4 × 4 mm. A sponge soaked in mitomycin 
C at a concentration of 0.25 mg/mL was applied intraoper-
atively on the sclera and underneath the conjunctiva for 3.9 
± 1.6 minutes, according to the patient’s condition. When 
the time since previous glaucoma surgery was less than 
three months, mitomycin C was not applied. After careful 
rinsing with saline, trabeculectomy and peripheral iridec-
tomy were performed. The scleral flap was closed with two 
to four 10-0 nylon sutures, and the Tenon capsule and con-
junctiva were sutured ensuring a watertight closure. 
Ahmed glaucoma valve implantation was performed fol-
lowing the conventional method. Brief ly, a fornix-based 
conjunctival incision was made, and the Tenon capsule was 
dissected with spring scissors. A rectangular-shaped 
half-thickness scleral flap was made in the supratemporal 
position of the limbus. The Ahmed glaucoma valve (S2 or 
S3 model; New World Medical Inc., Rancho Cucamonga, 
CA, USA) was secured to the sclera in the superotemporal 
quadrant 8-mm posterior to the limbus. An entrance site 
into the anterior chamber was made under the scleral flap 
with a 23-G needle. After temporary ligation using an 
absorbable suture, the tube of the valve was then passed 
through this 23-G opening into the anterior chamber, and 
a donor sclera was used to cover the flap and tube. 
Kaplan-Meier survival curves and log rank test were 
used to investigate and compare the success rates between 
the two procedures. To compare between the two groups, 
we used the Mann Whitney U-test or χ2 test. Statistical 
analyses were carried out using SPSS ver. 18.0 (SPSS Inc., 
Chicago, IL, USA).
Results
The mean follow-up period between the two groups was 
not significantly different; 85.0 months (range, 7 to 140 
months) for the trabeculectomy group and 94.6 months 
(range, 55 to 120 months) for the Ahmed glaucoma valve 
implantation group (p > 0.05 by Mann-Whitney U-test). 
The mean age of the patients at the time of surgery was 
86.3 months (range, 1 to 162) in the trabeculectomy group 
and 85.1 months (range, 5 to 227) in the valve implantation 
group. This difference was not statistically significant (p > 
0.05 by Mann-Whitney U-test). Both the preoperative IOP 
(trabeculectomy, 25.5 mmHg; valve implantation, 26.9 
mmHg) and the 48-month postoperative IOP (20.2 vs. 19.6 
mmHg in the trabeculectomy group and the Ahmed glau-
coma valve group, respectively) were similar in the two 
groups (p > 0.05, Mann-Whitney U-test). There was no 
significant difference between the two groups in the num-
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ber of glaucoma medications used either preoperatively or 
postoperatively (1.7 ±1.1 vs. 2.3 ±1.4, p=0.25; 1.7 ±1.1 vs. 1.8 
±1.5, p = 0.97, respectively). Preoperative IOP, 48-month 
postoperative IOP, visual acuity, and glaucoma medica-
tions are summarized in Tables 1 and 2. 
Table 3 presents the observed postoperative complica-
tions, which occurred in five (25%) of the trabeculecto-
my-operated eyes and one (9%) of the Ahmed-implanted 
eyes (p = 0.38). We observed one case of bleb-related en-
dophthalmitis in a trabeculectomy with mitomycin C pa-
tient (5%), which improved with injection of intravitreal 
antibiotics. In the Ahmed glaucoma valve group, we ob-
served one case of tube-cornea contact due to tube 
migration (9%), which required surgical repositioning. Ad-
ditionally, we saw two cases of shallow anterior chamber 
in the trabeculectomy group (10%), one of which required 
surgical intervention.
The success rates at one year intervals following the proce-
dures were as follows (reported as trabeculectomy vs. Ahmed 
valve implantation): 69% vs. 64% (12 months), 59% vs. 46% 
(24 months), and 42% vs. 36% (48 months). Additionally, the 
trabeculectomy group showed a 34% success rate after 96 
months of follow-up, while the valve implantation group 
showed a 24% success rate after 62 months. However, no sig-
nificant difference in the time to failure was observed be-
tween the groups (p = 0.529 by log rank test) (Fig. 1).
Discussion
While angle surgery, with a success rate of 70% to 90% [3-
5], is the primary surgical procedure utilized for congenital 
Table 1. Preoperative and postoperative characteristics of the trabeculectomy group
Patient 
no. Sex
Age at 
surgery 
(mon)
Mean 
follow-up 
(mon)
Preoperative Postoperative  (48 months after surgery)
VA IOP (mmHg)
Glaucoma 
medications (n) VA
IOP 
(mmHg)
Glaucoma 
medications (n)
1 M  18 124  UM 36 2 UM 23 1
2 M 111 140   0.05 19 1 NLP   0 0
3 M 121 130 0.1 22 1         1 15 0
4 F 74   20 0.1 28 5 0.1  4 0
5 F 161   29 0.6 28 3 0.6 13 0
6 F     1   60  UM 30 3   0.05 14 0
7 F 102   37 0.1 20 1   0.05 21 2
8 M 94 130 0.1 22 2   0.05 12 3
9 M  61   90  UM 31 1 0.2 24 3
10 M    3 133  UM 19 1 0.1 18 1
11 M    3 133  UM 20 1 0.3 18 1
12 M   61   99 0.1 22 1 0.2 23 3
13 M   15   59  UM 26 2 0.1 10 0
14 M   15   59  UM 28 2 UM 30 3
15 M 126 134 0.7 27 2 0.8 44 4
16 M 126 134 0.4 20 2 0.3 26 2
17 F 134   70 0.8 24 3 0.8 26 3
18 M 123     7   0.05 32 5     0.025   8 1
19 F   95    54 0.5 31 3 0.4 37 4
20 F   92    57 0.9 25 5 0.4 37 4
Mean ± SD  76.9 ± 51.5 85.0 ± 44.7 0.35 ± 0.32 25.5 ± 5.0 2.3 ± 1.4 0.32 ± 0.31 20.2 ± 11.3 1.8 ± 1.5
VA = visual acuity; IOP = intraocular pressure; UM = unmeasurable; NLP = no light perception.
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glaucoma, congenital glaucoma is not always successfully 
controlled using this technique. Therefore, when an unaccept-
able increase in IOP occurs after angle surgery, trabe c ul-
ectomy with or without mitomycin C is usually the next 
treatment choice. The reported success rates of treatments for 
refractory congenital glaucoma show wide variation (39% to 
94%) according to the study group, surgeon, success criteria, 
and follow-up period [6-13]. However, when trabeculectomy 
performed as a second operation also fails, it is unclear 
whether an additional trabeculectomy or implantation of a 
glaucoma drainage device is a better choice as the next in-
tervention. Re-trabeculectomy might be more effective than 
Table 2. Preoperative and postoperative characteristics of the Ahmed glaucoma valve group
Patient 
no. Sex
Age at 
surgery 
(mon)
Mean 
follow-up 
(mon)
Preoperative Postoperative (48 months after surgery)
VA IOP (mmHg)
Glaucoma 
medications (n) VA
IOP 
(mmHg)
Glaucoma 
medications (n)
1 M   12 120 UM 27 1 UM 32 1
2 M   12 120 UM 29 1 UM 28 1
3 F 116   64 0.2 24 2 0.1 24 3
4 F 227 119 HM 37 2 NLP   3 0
5 M    5 118 UM 18 1 0.1 17 1
6 M    5 118 UM 20 1 0.1 19 1
7 F   57 101 CF 26 2 CF 34 3
8 M 191   55   0.16 22 3 0.1 14 3
9 M 190   56 0.2 40 4 0.2 23 2
10 M 114 106 0.4 22 2 0.7 20 3
11 F    7   64 UM 31 0 UM   2 1
Mean ± SD 85.1 ± 86.3 94.6 ± 28.4 0.24 ± 0.11 26.9 ± 6.9 1.7 ± 1.1 0.22 ± 0.24 19.6 ± 10.4 1.7 ± 1.1
VA = visual acuity; IOP = intraocular pressure; UM = unmeasurable; HM = hand motion; NLP = no light perception; CF = counting 
finger.
Table 3. Postoperative complications
Trabeculectomy
( n = 20)
Ahmed glaucoma 
valve implantation
( n = 11)
Shallow anterior 
chamber
  2 (10) 0 (0)
Lenticular opacity 1 (5) 0 (0)
Endophthalmitis 1 (5) 0 (0)
Choroidal 
detachment
1 (5) 0 (0)
Tube-cornea 
contact
0 (0) 1 (9)
Total   5 (25) 1 (9)
Data are shown as number (%).
Fig. 1. Kaplan-Meier survival curve showing the proportion of 
eyes in which the operation was successful over time after trabe-
culectomy or Ahmed glaucoma valve implantation.
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the first surgery, but use of a glaucoma drainage device may 
also be an option when a previous trabeculectomy has 
failed. The efficacy of Ahmed glaucoma valve implantation, 
which is one of the most widely used glaucoma drainage 
devices, as the surgical choice for treatment of refractory 
congenital glaucoma has recently been reported and showed 
similar success rates to trabe culectomy (53% to 88%) [1,2]. 
However, studies comparing the results of those two surg eries 
in refractory congenital glaucoma after failure of the first 
trabeculectomy surgery have not yet been performed because 
of the rarity of the occurrence. There fore, we evaluated the 
success rates and complications of a second trabeculectomy 
versus those of an Ahmed glaucoma valve implantation fol-
lowing a failed first trabeculectomy.
Using the log rank test, we found that the two had com-
parable success rates. Although the trabeculectomy group 
showed slightly higher success rates than the Ahmed glau-
coma valve group, there was no significant difference 
between the two groups (p = 0.529). However, with respect 
to postoperative complications, trabeculectomy led to more 
complications; five cases (25%) in the trabeculectomy 
group showed complications, while tube migration (9%) was 
the only observed complication in the Ahmed glauc oma 
valve implantation group. 
The success rate we observed was lower than that found 
by others for this type of primary surgery. This may be 
due to the fact that all subjects included in this study had 
already experienced failures of the angle surgery and 
trabeculectomy, and previous failure of surgery is known 
to be a poor prognostic factor for subsequent surgery. To 
the best of our knowledge, this is the first report of success 
rates of additional surgical intervention (trabeculectomy or 
Ahmed glaucoma valve implantation) for refractory 
congenital glaucoma in patients who underwent a previous 
failed trabeculectomy. Therefore, the findings of this study 
will inform the choice of surgery for repeatedly uncon-
trolled congenital glaucoma. 
The main limitations of our study were the small num-
ber of participants and the fact that it was a retrospective 
study. Because congenital glaucoma has such a low preva-
lence, it was difficult to find patients who had undergone 
primary operations followed by re-operation, and this lim-
ited our sample size. On the other hand, the long follow-up 
period was one of the major strengths of our study.
In conclusion, this study revealed that both trabeculecto-
my and Ahmed glaucoma valve implantation resulted in 
unsatisfactory IOP control in the majority of cases of pri-
mary congenital glaucoma in patients who had previously 
undergone trabeculectomy with mitomycin C. There was 
no significant difference in surgical outcome between the 
two groups. Both groups experienced complications follow-
ing their respective procedures, although the complications 
arising from trabeculectomy were more frequent and seri-
ous than those arising from Ahmed glaucoma valve 
implantation. Additional research is needed to find a more 
successful method for treating primary congenital glaucoma 
patients who have previously undergone glaucoma surgery.
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